Physician profile
Soham Roy
NPI 1649295494
$33,652.64
in general payments reported to CMS, 2019-2025
22 companies · $9,104 in 2025
The $9,104 reported for 2025 was more than what 97% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $6,548 · 2021: $736 · 2022: $1,046 · 2023: $436 · 2024: $3,018 · 2025: $9,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,453 · Food and Beverage: $2,252 · Travel and Lodging: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,453.00 |
| Food and Beverage | $2,251.64 |
| Travel and Lodging | $853.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,648.04 | 2019 | |
| Smiths Medical Asd, INC. | $7,116.98 | 2019-2021 | |
| Icu Medical INC | $6,853.23 | 2025 | Bivona |
| Smith+Nephew, INC. | $1,940.88 | 2024-2025 | Tula, Halo |
| Genzyme Corporation | $1,728.00 | 2025 | |
| Medtronic, INC. | $924.26 | 2022-2024 | Stealthstation S8 Platform, Propel, Sinuva |
| Grace Medical, INC. | $665.98 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $516.67 | 2019 | |
| Acclarent, INC | $488.52 | 2020-2024 | Acclarent Aera, Relieva Spinplus |
| Stryker Corporation | $237.59 | 2024-2025 | Na, Sonopet Iq, Core |
| Cochlear Americas | $209.94 | 2019 | |
| Kls-Martin L.P. | $182.66 | 2023 | |
| Advanced Bionics, LLC | $176.02 | 2022 | |
| Integra Lifesciences Corporation | $155.18 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Regeneron Pharmaceuticals, INC. | $150.00 | 2025 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $144.54 | 2021 | |
| Novo Nordisk INC | $117.32 | 2021 | |
| Preceptis Medical, INC. | $109.42 | 2022-2024 | Hummingbird Tympanostomy Tube System |
| Cook Medical LLC | $98.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.99 | 2021-2023 | |
| Aerin Medical INC. | $64.67 | 2024 | |
| Evoendo, INC | $28.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soham Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.